 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
News Briefs Burkina Faso to Purchase Generic AIDS Drugs From Indian CompanyApril 23, 2003 The government of Burkina Faso on Tuesday signed a contract to purchase generic AIDS drugs from the Indian pharmaceutical firm Cipla. Health Minister Alain Yoda said the deal will bring down prices of AIDS medicine to $37-$70 per month. Under an earlier agreement reached with a European company, treatment cost up to $150 a month. However, prices remain "an obstacle for the treatment of a great number of people who really need them," Yoda said. About 6.5 percent of Burkina Faso's 12 million citizens are infected with HIV, according to a recent UN study. Currently only 675 people in the country are being treated with AIDS drugs, Yoda said. About 45 percent of the nation's population survives on less than $120 a year. Associated Press 04.22.03; Brahima Ouedraogo  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
|
|
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
